874.00
0.54%
-3.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché NVDA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$877.35
Aprire:
$872.4
Volume 24 ore:
1.26M
Capitalizzazione di mercato:
$2.19T
Reddito:
$60.92B
Utile/perdita netta:
$29.76B
Rapporto P/E:
211.11
EPS:
4.14
Flusso di cassa netto:
$27.02B
1 W Prestazione:
+5.87%
1M Prestazione:
-3.43%
6M Prestazione:
+112.00%
1 anno Prestazione:
+214.47%
NVIDIA Corp Stock (NVDA) Company Profile
Nome
NVIDIA Corp
Settore
Industria
Telefono
408-486-2000
Indirizzo
2788 San Tomas Expressway, Santa Clara, CA
NVIDIA Corp Stock (NVDA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-16 | Iniziato | Evercore ISI | Outperform |
2024-04-11 | Reiterato | Raymond James | Strong Buy |
2024-04-10 | Reiterato | Morgan Stanley | Overweight |
2024-04-08 | Reiterato | KeyBanc Capital Markets | Overweight |
2024-03-22 | Reiterato | UBS | Buy |
2024-03-21 | Reiterato | TD Cowen | Outperform |
2024-03-07 | Reiterato | Mizuho | Buy |
2024-02-22 | Reiterato | BofA Securities | Buy |
2024-02-22 | Reiterato | Cantor Fitzgerald | Overweight |
2024-02-22 | Reiterato | Citigroup | Buy |
2024-02-22 | Reiterato | DA Davidson | Neutral |
2024-02-22 | Reiterato | Deutsche Bank | Hold |
2024-02-22 | Reiterato | Goldman | Buy |
2024-02-22 | Reiterato | HSBC Securities | Buy |
2024-02-22 | Reiterato | JP Morgan | Overweight |
2024-02-22 | Reiterato | Jefferies | Buy |
2024-02-22 | Reiterato | KeyBanc Capital Markets | Overweight |
2024-02-22 | Reiterato | Mizuho | Buy |
2024-02-22 | Reiterato | Morgan Stanley | Overweight |
2024-02-22 | Reiterato | Needham | Buy |
2024-02-22 | Reiterato | Stifel | Buy |
2024-02-22 | Reiterato | TD Cowen | Outperform |
2024-02-22 | Reiterato | The Benchmark Company | Buy |
2024-02-22 | Reiterato | Truist | Buy |
2024-02-22 | Reiterato | UBS | Buy |
2024-02-22 | Reiterato | Wedbush | Outperform |
2024-02-22 | Reiterato | Wolfe Research | Outperform |
2024-02-16 | Iniziato | Loop Capital | Buy |
2024-02-15 | Reiterato | Piper Sandler | Overweight |
2024-02-13 | Reiterato | UBS | Buy |
2024-02-05 | Reiterato | Goldman | Buy |
2024-01-23 | Iniziato | Cantor Fitzgerald | Overweight |
2024-01-03 | Iniziato | DA Davidson | Neutral |
2023-11-22 | Reiterato | BMO Capital Markets | Outperform |
2023-11-22 | Reiterato | Bernstein | Outperform |
2023-11-22 | Reiterato | BofA Securities | Buy |
2023-11-22 | Downgrade | Edward Jones | Buy → Hold |
2023-11-22 | Reiterato | Goldman | Buy |
2023-11-22 | Reiterato | JP Morgan | Overweight |
2023-11-22 | Reiterato | Mizuho | Buy |
2023-11-22 | Reiterato | Morgan Stanley | Overweight |
2023-11-22 | Reiterato | Rosenblatt | Buy |
2023-11-22 | Reiterato | Truist | Buy |
2023-11-22 | Reiterato | UBS | Buy |
2023-11-22 | Reiterato | Wells Fargo | Overweight |
2023-10-11 | Reiterato | TD Cowen | Outperform |
2023-08-24 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
2023-08-24 | Reiterato | Rosenblatt | Buy |
2023-08-24 | Aggiornamento | Stifel | Hold → Buy |
2023-08-24 | Reiterato | TD Cowen | Outperform |
2023-08-21 | Reiterato | HSBC Securities | Buy |
2023-08-21 | Reiterato | KeyBanc Capital Markets | Overweight |
2023-08-09 | Reiterato | Stifel | Hold |
2023-07-24 | Reiterato | Mizuho | Buy |
2023-07-20 | Iniziato | Wolfe Research | Outperform |
2023-07-17 | Reiterato | Citigroup | Buy |
2023-07-14 | Reiterato | Truist | Buy |
2023-07-11 | Reiterato | KeyBanc Capital Markets | Overweight |
2023-06-30 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
2023-06-16 | Reiterato | Morgan Stanley | Overweight |
2023-05-25 | Aggiornamento | Craig Hallum | Hold → Buy |
2023-05-25 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2023-05-25 | Aggiornamento | Wedbush | Neutral → Outperform |
2023-04-19 | Reiterato | BofA Securities | Buy |
2023-04-18 | Aggiornamento | HSBC Securities | Reduce → Buy |
2023-03-27 | Reiterato | UBS | Buy |
2023-03-21 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
2023-03-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2023-03-02 | Ripresa | Raymond James | Strong Buy |
2023-02-23 | Aggiornamento | Goldman | Neutral → Buy |
2023-02-21 | Reiterato | BMO Capital Markets | Outperform |
2023-02-16 | Downgrade | DZ Bank | Buy → Sell |
2023-01-23 | Reiterato | Truist | Buy |
2022-12-19 | Reiterato | Needham | Buy |
2022-12-15 | Iniziato | HSBC Securities | Reduce |
2022-11-17 | Aggiornamento | Summit Insights | Hold → Buy |
2022-11-16 | Ripresa | Credit Suisse | Outperform |
2022-09-08 | Iniziato | Stifel | Hold |
2022-09-02 | Downgrade | Daiwa Securities | Outperform → Neutral |
2022-08-08 | Downgrade | Craig Hallum | Buy → Hold |
2022-07-13 | Reiterato | Susquehanna | Positive |
2022-05-26 | Ripresa | The Benchmark Company | Buy |
2022-05-03 | Ripresa | Morgan Stanley | Equal-Weight |
2022-04-13 | Aggiornamento | New Street | Neutral → Buy |
2022-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-03-15 | Reiterato | Cowen | Outperform |
2022-03-07 | Ripresa | Goldman | Neutral |
2022-02-17 | Downgrade | Summit Insights | Buy → Hold |
2021-11-18 | Reiterato | BofA Securities | Buy |
2021-11-18 | Reiterato | Craig Hallum | Buy |
2021-11-18 | Reiterato | Deutsche Bank | Hold |
2021-11-18 | Reiterato | JP Morgan | Overweight |
2021-11-18 | Reiterato | Jefferies | Buy |
2021-11-18 | Reiterato | KeyBanc Capital Markets | Overweight |
2021-11-18 | Reiterato | Mizuho | Buy |
2021-11-18 | Reiterato | Needham | Buy |
2021-11-18 | Reiterato | Piper Sandler | Overweight |
2021-11-18 | Reiterato | Raymond James | Strong Buy |
2021-11-18 | Reiterato | Truist | Buy |
2021-11-15 | Reiterato | Citigroup | Buy |
2021-11-15 | Reiterato | UBS | Buy |
2021-11-12 | Downgrade | Wedbush | Outperform → Neutral |
2021-10-22 | Aggiornamento | Summit Insights | Sell → Buy |
2021-10-05 | Reiterato | KeyBanc Capital Markets | Overweight |
2021-09-17 | Reiterato | BofA Securities | Buy |
2021-08-20 | Ripresa | The Benchmark Company | Buy |
2021-08-19 | Downgrade | Summit Insights | Hold → Sell |
2021-08-12 | Reiterato | Evercore ISI | Outperform |
2021-08-12 | Reiterato | UBS | Buy |
2021-08-12 | Reiterato | Wells Fargo | Overweight |
2021-08-04 | Reiterato | Rosenblatt | Buy |
2021-07-15 | Reiterato | Mizuho | Buy |
2021-07-08 | Reiterato | Oppenheimer | Outperform |
2021-07-06 | Reiterato | KeyBanc Capital Markets | Overweight |
2021-07-01 | Reiterato | BMO Capital Markets | Outperform |
2021-06-22 | Reiterato | Raymond James | Strong Buy |
2021-06-18 | Reiterato | BofA Securities | Buy |
2021-06-17 | Reiterato | Jefferies | Buy |
2021-05-27 | Reiterato | BofA Securities | Buy |
2021-05-27 | Reiterato | Cowen | Outperform |
2021-05-27 | Aggiornamento | Craig Hallum | Hold → Buy |
2021-05-20 | Ripresa | KeyBanc Capital Markets | Sector Weight |
2021-05-05 | Iniziato | Robert W. Baird | Outperform |
2021-04-15 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2021-04-13 | Reiterato | Cowen | Outperform |
2021-04-13 | Reiterato | Rosenblatt | Buy |
2021-02-25 | Reiterato | Cowen | Outperform |
2021-02-22 | Reiterato | Susquehanna | Positive |
2021-02-03 | Aggiornamento | New Street | Sell → Neutral |
2020-11-12 | Reiterato | Cascend Securities | Buy |
2020-10-09 | Downgrade | New Street | Neutral → Sell |
2020-10-06 | Reiterato | BMO Capital Markets | Outperform |
2020-10-02 | Reiterato | Wedbush | Outperform |
2020-09-15 | Reiterato | Needham | Buy |
2020-09-02 | Reiterato | BofA Securities | Buy |
2020-09-02 | Reiterato | Credit Suisse | Outperform |
2020-09-02 | Reiterato | Goldman | Buy |
2020-09-02 | Reiterato | Mizuho | Buy |
2020-09-02 | Reiterato | RBC Capital Mkts | Outperform |
2020-09-02 | Reiterato | The Benchmark Company | Buy |
2020-08-20 | Reiterato | Morgan Stanley | Equal-Weight |
2020-08-20 | Reiterato | Needham | Buy |
2020-08-20 | Reiterato | RBC Capital Mkts | Outperform |
2020-08-20 | Reiterato | Raymond James | Outperform |
2020-08-20 | Reiterato | Rosenblatt | Buy |
2020-08-20 | Reiterato | Susquehanna | Positive |
2020-08-20 | Reiterato | Truist | Buy |
2020-08-20 | Reiterato | Wedbush | Outperform |
2020-08-20 | Reiterato | Wells Fargo | Overweight |
Mostra tutto
NVIDIA Corp Borsa (NVDA) Ultime notizie
Here Are My 3 Top Artificial Intelligence (AI) Stocks to Buy Right Now
The Motley Fool
Is Nvidia Stock a "No-Brainer" Headed to $1,125? 1 Wall Street Analyst Thinks So.
The Motley Fool
Should Invesco S&P 500 Pure Growth ETF (RPG) Be on Your Investing Radar?
Zacks Investment Research
Should Invesco QQQ (QQQ) Be on Your Investing Radar?
Zacks Investment Research
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Amazon, NextEra Energy and Marriott International
Zacks Investment Research
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
The Motley Fool
NVIDIA Corp Azioni (NVDA) Dati Finanziari
NVIDIA Corp (NVDA) Reddito 2024
NVDA ha riportato un ricavo (TTM) di $60.92 miliardi per il trimestre terminato il 2024-01-31, un +125.85% salita anno su anno.
NVIDIA Corp (NVDA) Reddito netto 2024
NVDA l'utile netto (TTM) è stato di $29.76 miliardi per il trimestre terminato il 2024-01-31, un +581.30% aumento anno su anno.
NVIDIA Corp (NVDA) Flusso di cassa 2024
NVDA ha registrato un flusso di cassa disponibile (TTM) di $27.02 miliardi per il trimestre conclusosi con 2024-01-31, un +609.59% aumento anno su anno.
NVIDIA Corp (NVDA) Utile per azione 2024
L'utile per azione (TTM) di NVDA è stato pari a $11.93 per il trimestre terminato il 2024-01-31, un +585.63% crescita anno su anno.
NVIDIA Corp Azioni (NVDA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
STEVENS MARK A | Director |
Apr 05 '24 |
Sale |
879.97 |
22,700 |
19,975,240 |
1,052,133 |
PERRY MARK L | Director |
Apr 02 '24 |
Sale |
887.89 |
7,000 |
6,215,259 |
116,000 |
STEVENS MARK A | Director |
Mar 28 '24 |
Sale |
905.65 |
11,000 |
9,962,150 |
1,074,833 |
Dabiri John | Director |
Mar 25 '24 |
Sale |
940.00 |
128 |
120,320 |
2,055 |
Robertson Donald F Jr | Principal Accounting Officer |
Mar 22 '24 |
Sale |
911.62 |
450 |
410,229 |
49,815 |
STEVENS MARK A | Director |
Mar 07 '24 |
Sale |
919.33 |
21,750 |
19,995,508 |
1,085,833 |
COXE TENCH | Director |
Mar 05 '24 |
Sale |
850.10 |
200,000 |
170,020,366 |
3,097,136 |
Drell Persis | Director |
Mar 05 '24 |
Sale |
845.13 |
5,000 |
4,225,640 |
2,106 |
STEVENS MARK A | Director |
Mar 04 '24 |
Sale |
853.54 |
12,000 |
10,242,502 |
1,107,583 |
STEVENS MARK A | Director |
Feb 26 '24 |
Sale |
800.74 |
5,000 |
4,003,700 |
1,119,583 |
Capitalizzazione:
|
Volume (24 ore):